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Abstract
Background—While physical activity reduces breast cancer risk, issues critical to providing
clear public health messages remain to be elucidated. These include: the minimum duration and
intensity necessary for risk reduction; the optimal time period for occurrence; as well as subgroup
effects, particularly with regard to tumor heterogeneity and body size.
Methods—The purpose of this report is to investigate the relationship between recreational
physical activity (RPA) and breast cancer risk, in addition to characterizing the joint effects of
activity level, weight gain and body size, using a population-based sample of 1504 cases (N=233
in-situ, N=1271 invasive) and 1555 controls (aged 20–98 years) from the Long Island Breast
Cancer Study Project.
Results—We observed a non-linear dose response association between breast cancer risk and
RPA during the reproductive period and after menopause. Women in the third quartile of activity
experienced the greatest benefit with an approximate 30% risk reduction for reproductive (odds
ratio [OR]=0.67; 95% confidence interval [CI], 0.48–0.94) and postmenopausal activity
(OR=0.70; 95% CI, 0.52–0.95). We observed little to no difference by intensity or hormone
receptor status. Joint assessment of RPA, weight gain and body size revealed that women with
unfavorable energy balance profiles were at increased breast cancer risk. We observed a
significant multiplicative interaction between RPA and adult weight gain (p=0.033).
Conclusions—RPA at any intensity level during the reproductive and postmenopausal years
have the greatest benefit for reducing breast cancer risk. Substantial postmenopausal weight gain
may eliminate the benefits of regular activity.
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Despite the recent downward trend in the rates of breast cancer, with over 200,000 women
newly diagnosed with this disease per year1 it remains an important public health concern.
While there has been considerable research in identifying risk factors for breast cancer, a
small proportion are amenable to intervention. Physical Activity (PA) appears to play an
important role in the reduction of both pre- and postmenopausal breast cancer risk2–5. Given
that three-quarters of the United States (US) population participates in some PA6; it is
conceivably one of the most important lifestyle risk factors associated with the breast
cancer.
A number of important issues critical to developing public health messages and/or
interventions to reduce breast cancer risk, with respect to PA, remain to be elucidated. These
include the minimum duration and intensity of PA necessary for risk reduction, as well as
the optimal time periods at which activity should occur. A more comprehensive
understanding of how this association varies within subgroups may allow us to better target
susceptible populations of women for public health messaging and intervention. It may also
advance our knowledge of breast cancer etiology. Analyses of subgroups defined by
hormone receptor (HR) status may better inform us about the impact of PA in heterogeneous
breast tumors. Given the strong association between adiposity and PA7, simultaneous
examination of body weight, PA, and breast cancer risk could help to uncover mechanisms
through which PA acts.
The purpose of this report was to: (1) investigate the association between recreational
physical activity (RPA), at several points throughout the life-course, and risk of developing
breast cancer using data from a large population-based case-control study; (2) explore the
association between RPA and HR status to understand if RPA preferentially reduces the risk
of HR-positive breast cancers; and (3) characterize the joint effects of activity level and
weight gain or body size. We hypothesized that RPA across the life-course was most
important for breast cancer risk reduction and that RPA preferentially reduces the risk of
HR-positive breast cancers. We also anticipated that women with unfavorable energy
balance profiles would be at increased risk of breast malignancy.
Methods
The Long Island Breast Cancer Study Project (LIBCSP) is a population-based study
conducted among adult English-speaking female residents of Nassau and Suffolk counties,
Long Island, NY. Data used for the analysis reported here include: participants of the case-
control study; the case-control interview; and the medical record review. Details of the study
methods have been described previously8. Institutional Review Board approval was obtained
from all participating institutions.
Study Population
Eligible LIBCSP cases were women of all ages (age range 20–98 years) and races newly
diagnosed with first primary in-situ or invasive breast cancer between August 1, 1996, and
July 31, 1997. Cases were identified through daily or weekly contact to 28 hospitals on Long
Island and three large tertiary care hospitals in New York City. Eligible controls were
women without a personal history of breast cancer and were frequency matched to the
expected age distribution of cases by 5-year age group. Controls were identified through
random digit dialing for women under age 65 years and the Health Care Finance
Administration rosters for women age 65 years and greater. All data were collected through
a two-hour interviewer-administered structured questionnaire conducted by a trained
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interviewer in the respondent’s home. Interview response among eligible cases and controls
were 82.1% (N=1508) and 62.8% (N=1556), respectively.
RPA Assessment
As part of the LIBCSP case-control questionnaire, interviewers asked participants about
their involvement in RPA using a modified instrument developed by Bernstein and
colleagues9. Respondents were asked about all RPA in which they had engaged for at least
one hour per week and three months or more in any year over the life-course. Participants
who replied never having participated in RPA were classified as having no RPA. Among
women who replied ever having participated in RPA, interviewers obtained the activity
name, the ages the activity was started and stopped, and the number of hours per week (hrs/
wk) and months per year the activity was performed. These data were summed across all
activities for each year of a woman’s life, providing a lifetime composite score of exercise
duration from menarche (left truncated) to reference date. Similarly, for women classified as
ever having participated in RPA, metabolic equivalents of energy expenditure (MET) scores
were assigned to each reported activity according to a published database10. Scores were
multiplied by the number of hrs/wk the participant reported engaging in the activity and
were summed across all activities. For this ancillary study complete RPA data were obtained
for 1,504 cases and 1,555 controls.
Average hrs/wk and average MET hrs/wk of RPA were evaluated in four etiologically
relevant time periods based on known windows of breast cancer susceptibility: from
menarche to first birth (among parous women), to approximate activity in adolescence and
early adulthood; from first birth to menopause (among parous postmenopausal women), to
approximate activity during the reproductive years; from menopause to reference date
(among postmenopausal women), to approximate activity during the postmenopausal years;
and from menarche to reference date, to approximate activity across the lifespan.
Covariate Assessment
In addition to RPA, the case-control questionnaire queried women on demographic
characteristics; reproductive, medical and environmental histories; cigarette and alcohol use;
use of exogenous hormones; energy intake; and select anthropometric measurements.
Body size assessments included weight, height, and weight change by decade of life.
Participants self-reported height to the nearest inch and weight to the nearest pound at age
20 and 1-year prior to reference date. Respondents also reported their weight in each decade
of life starting at age 20. Change in weight during two time periods were calculated using
methods previously described11. Weight change from the 20s to 1-year prior to reference
date was used to estimate adulthood weight change, while weight change from the 50s to 1-
year prior to reference date estimated postmenopausal weight change. Body mass index
(BMI) at age 20 and reference date were calculated for each participant based on the
following formula: weight (kg)/height(m)2.
Among eligible cases clinical data on the characteristics of their breast cancer diagnosis,
including HR status, were obtained from medical records.
Statistical Methods
Unconditional logistic regression12 was used to estimate odds ratios (ORs) and 95%
confidence intervals (CIs) for associations between breast cancer and RPA. All statistical
models were implemented in SAS v.9.1 (Cary, NC).
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RPA for the four time periods were evaluated independently as dichotomous variables
(using the control median), quartiles, deciles, and as continuous variables. We additionally
explored flexible modeling using quadratic functions and linear splines to determine which
construction best described the shape of the data. Results produced using quartiles are
reported here, as it most adequately captured the dose-response shape of the data employing
the fewest number of parameters. To optimize study power for assessment of heterogeneity
by HR status and effect measure modification by weight change and BMI, RPA was
classified based on the control median (<control median=low RPA; ≥control median=high
RPA). Among women who gained weight we classified participants as high (≥control
median) or low (<control median) weight gainers for the time periods from age 20 to
referent date and from age 50 to referent date. These two groups, along with weight
maintainers (+/− 3kg) and weight losers, define our weight change variable. We categorized
BMI using the standard World Health Organization (WHO) classifications (<18.5; 18.5–
24.9; 25.0–29.9; and ≥30).
We identified potential confounders through the known epidemiology of breast cancer and
analysis of causal diagrams13. Education (categorical), first degree family history of breast
cancer (yes/no), history of benign breast disease (yes/no), income (categorical), lactation
history (ever/never), use of oral contraceptives (ever/never), parity (categorical), and
smoking history (never, current, former) were considered potential confounders. Covariates
resulting in greater than a 10% change in the regression coefficient when added to the
model, compared to a model without the covariate, were considered confounders in our final
analysis14. None of the variables assessed met our criteria. Thus, final multivariable models
were adjusted only for the frequency matching factor, 5-year age group.
The main effect of RPA on breast cancer risk was assessed among all women combined as
well as within strata of menopausal status. The effect of RPA among postmenopausal
women in all four time periods was evaluated by HR status stratifying cases into two groups
using information on estrogen receptor (ER) and progesterone receptor (PR) status15:
women with tumors that showed any hormone responsiveness (ER+/PR+, ER+/PR−, and ER
−/PR+) versus none (ER−/PR−).
We examined interactions between RPA, weight change, BMI and postmenopausal breast
cancer risk using multiplicative and additive scales. Weight change and BMI were
investigated as potential effect measure modifiers based on our a priori study aims.
Participants who reported not partaking in RPA over any period during the life-course and
had neither gained nor lost weight as an adult were used as a common referent group for the
RPA-weight change interactions, while women with no life-course RPA and BMI between
18.5 and 24.99 were used as a common referent group for the RPA-BMI interaction.
Departures from the multiplicative null were assessed using the likelihood ratio test,
employing α ≤ 0.2 as a cutoff for statistical significance16. Departures from the additive null
were evaluated by estimating the interaction contrast ratio (ICR)17. Using indicator terms for
RPA, weight change, and BMI variables the magnitude of the additive interaction effect was
determined by estimating the adjusted ICR based on the following formula: ICR OR11–
OR01–OR10+1 and its respective confidence interval obtained by ICR±1.96 SE(ICR)18.
Results
Breast cancer risk among all women was only slightly reduced with ever participation in
RPA (OR=0.94; 95% CI, 0.79–1.12) and varied modestly by menopausal status (OR=1.15;
95% CI, 0.80–1.64 for premenopausal women and OR=0.87; 95% CI, 0.71–1.08 for
postmenopausal women). While we observed no difference in effects when intensity levels
were considered (average MET hours/week) compared to the analysis including duration
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alone (data not shown), we did observe some variation by timing of RPA (Table 1). Among
premenopausal women neither RPA during adolescence and early adulthood nor RPA over
the life-course were associated with breast cancer risk. In contrast, consistent inverse
associations between RPA and breast cancer risk were observed among postmenopausal
women. Compared to the other time periods, RPA during the reproductive years showed the
strongest association. Parous postmenopausal women in the third quartile of activity (10 to
19 hrs/wk) had an age-adjusted OR of 0.67 (95% CI, 0.48–0.94) compared to women who
were inactive. The association was also apparent for postmenopausal women in the third
quartile of activity performed after menopause (OR: 0.70; 95% CI: 0.52–0.95). Even upon
restricting our analyses to parous women creating comparable groups across time periods,
we find that the most relevant period for breast cancer risk reduction is during the
reproductive period and following menopause (data not shown). Similarly, we found
comparable effect estimates for invasive and in-situ cases (data not shown), and thus report
findings for total breast cancer.
Among parous postmenopausal women, RPA during the reproductive period was associated
with a 25% risk reduction of HR-positive breast cancer (OR=0.75; 95% CI, 0.55–1.03), and
a 4% risk reduction among HR-negative cases (OR=0.96; 95% CI, 0.58–1.58) (Table 2).
While we observed no statistical differences between HR-positive and HR-negative cases,
our exploratory analysis suggests that breast cancer risk reduction from reproductive RPA
may apply to women who have the most common types of postmenopausal breast cancer,
namely HR-positive tumors. We found no striking results among any of the other three time
periods assessed. We also estimated the association between RPA and ER status and found
little differences in the two outcome groups. Our data indicate a 15% risk reduction for ER−
breast tumors and a 20% risk reduction for ER+ breast tumors among postmenopausal
women who were classified as having high reproductive RPA (data not shown).
Our data show that within strata of weight change or BMI women who engage in high
activity are at a lower risk of breast cancer than women in the same classification who are
inactive (Table 3). High adulthood weight gain was associated with a 28% increased risk of
breast cancer among women who engaged in no activity over the life-course (95% CI, 0.68–
2.39), while approximately null associations were observed among high gainers reporting
high levels of RPA during the same time period (OR=1.02; 95% CI, 0.55–1.87). Similar
patterns were observed for high postmenopausal weight gain and obesity although RPA was
not shown to mitigate the deleterious effects of high postmenopausal weight gain on breast
cancer risk. We found a statistically significant interaction (p=0.033) between lifetime RPA
and weight gain from age 20 on the multiplicative scale (Table 3). There was no evidence of
interaction on the additive scale.
Discussion
We observed stronger effects for PA among postmenopausal women compared to
premenopausal women, which is consistent with previously published data2–5. The effects
obtained using average MET-hours as a composite measure of intensity and duration were
similar to estimates observed for duration alone. Our results did indicate some variations in
risk based on timing of RPA occurrence. We found that RPA over the life-course,
particularly during the reproductive (among parous women) and postmenopausal years,
decreases breast cancer risk. The observed inverse associations are consistent with most
other studies that have examined the effect of PA on breast cancer risk reduction4,5,19,20
where an average 25% risk reduction is reported5,19.
Results from the current study show that RPA during the reproductive years and after
menopause are most critical for risk reduction. Our observations likely reflect the role of PA
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in energy balance and obesity mediated mechanisms (e.g. insulin resistance and
inflammation) which most commonly manifest after adolescence. We found little evidence
of benefit from early-life activity which is consistent with most 21–24, but not all25,26,
investigations. While few studies are able to assess activity across the life-course, those that
have a comprehensive lifetime assessment of PA report inverse associations2,27. Using a
similar PA assessment to the current study, Bernstein and colleagues report a 17% risk
reduction among women in the highest quartile of lifetime activity compared inactive
women27. We also found a 17% risk reduction for lifetime RPA among the most active
women despite our wide age distribution (age 20–98 vs. age 35–64). Given the noticeable
difference in age distribution for this study, we re-assed our main effects restricted to
women age <80, <70, and <60 years, respectively. We found no difference between these
restricted analyses and the analyses among women of all ages (data not shown).
Contrary to a recent review which reports an inverse dose-response association between PA
and breast cancer risk5, the observed effect for RPA did not decrease in a dose-response
manner. A lack of linear dose-response could be interpreted as weak evidence of an
association between RPA and breast cancer risk. However, it is possible that the RPA breast
cancer association may follow a J- or U-shape. In the LIBCSP, a substantial proportion of
women reported high levels of RPA permitting us to consider a wide range of effects.
Studies indicate that sustained PA is a strong inducer of lipid peroxidation and reactive
oxygen species28,29. These changes may cause DNA damage, mutations in proto-oncogenes
or tumor-suppressor genes and, if unrepaired, transformation of normal epithelium to a
malignant phenotype30,31. Studies also show that vigorous physical exercise may depress
immune function32. Inconsistencies in dose-response may therefore reflect the underlying
distribution of RPA among study participants. For example, the median lifetime RPA in the
Women’s Contraceptive and Reproductive Experiences study was 1.2 hrs/week27, while the
median lifetime RPA was 6.35 hrs/week in the current study. Our results, in combination
with animal and clinical data, suggest that sustained involvement in vigorous activity may
mitigate the known protective effect of RPA resulting in a J- or U-shaped association.
Although our results do not show statistically significant associations among HR-positive or
HR-negative cases, they do suggest that RPA during the reproductive period may
preferentially decrease HR-positive tumors. This further supports the hypothesis that breast
cancer is a heterogeneous disease with varying etiologic pathways33. When we assessed ER-
negative cases compared to ER-positive cases the patterns of association were not markedly
different between groups (OR=0.80 and 0.85, respectively), suggesting that the role of PA in
risk reduction is not entirely mediated through an estrogen pathway. It should be noted that
in these analyses the cell sizes were particularly small for ER−/PR− cases in comparison
with any positive cases. Our findings are comparable to other reports that find no difference
in the PA-breast cancer association by hormone receptor status27,34,35, but in contrast to
some studies which report greater decreases among ER- cases compared to ER+ cases35,36,
and still others which show stronger associations for ER+ tumors37,38.
In this large case-control study we found that breast cancer risk was generally the greatest
among women jointly classified as having high levels of adiposity and little RPA. While the
results were consistent with our hypothesis, we found only one multiplicative interaction and
no evidence of additive interaction among our indicators of energy balance. It is noteworthy
that postmenopausal RPA reduced the adverse effects of obesity on breast cancer risk to
approximately null, but did not completely obliterate the effect of postmenopausal weight
gain. These observations likely reflect differences in the effect of weight maintenance vs.
weight gain39 with the latter being potentially more deleterious during the postmenopausal
years11. The timing of weight gain may therefore be an important factor in understanding
the weight-PA interaction among postmenopausal populations. While stratification would
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help us better uncover these associations, even with a study sample of 3000 women we did
not have adequate statistical power to evaluate the three-way joint effects of weight gain,
BMI and RPA. Few studies have examined modification by weight change40–44. In the only
other study42 to assess the joint effects of weight gain and PA using the common referent
analysis, investigators also reported that high PA did not eliminate the excess breast cancer
risk caused by weight gain.
Studies of PA and breast cancer risk have mixed results on the modifying effects of BMI.
Several investigations have found risk reductions only among physically active lean
women43–48, while others report risk reductions in all BMI categories42,49. A 2008 review
of 16 studies estimated that risk reductions were approximately 25% among women with
BMI between 22 and 25 kg/m2 and 20% among women with BMI ≥25 kg/m2. There were
near null effects of PA on breast cancer risk among women with BMI ≥30 kg/m2, although
few studies reported effects in this stratum5. Our results are consistent with this review.
The strengths of our study are numerous and include its population-based design and large
sample size which increased our power to detect small associations, assess subgroup
analyses, and evaluate joint effects of weight indicators and RPA. Our RPA assessment
provided a wide range of activities that contribute to energy expenditure in this population
of women. Multiple time periods throughout the lifespan were evaluated as well as several
parameters of RPA. While in this analysis we were unable to assess all potential sources of
PA, a comprehensive 2008 review of physical activity parameters and breast cancer risk
showed that the greatest risk reductions were for RPA (20% risk reduction). Activity related
to occupation, transportation and living each resulted in ~14% risk reduction5. Few studies
have considered PA from all sources. Given the high socioeconomic status and of Long
Island women8 we expected little variation by alternative sources of activity and anticipate
that any additional variation would result in a more pronounced risk reduction. Although our
RPA measurement has not been validated, this instrument was useful in revealing important
relationships between exercise and breast cancer risk in other epidemiologic studies9,50.
Despite the large overall sample size a limitation of this study was its relatively homogenous
population. Study participants were on average more affluent and educated than the US
population. Results are therefore not readily applicable to all women. Our study population
included few women who were nulliparous8. We were therefore unable to perform a
stratified analysis by nulliparity when assessing the effect of timing on breast cancer risk.
Errors in reporting or differential reporting by cases and controls have the potential to bias
the study results. A spurious inverse association could have occurred if PA was
systematically underreported by cases or over reported by controls. While regular PA, like
other healthy behaviors, may result in some social desirability, we suspect that these biases
would persist in both case and control groups resulting in non-differential misclassification
of RPA. Given the exposure variable was not simply dichotomous however, the direction of
such a bias would be unpredictable51. To reduce the probability of recall bias and
misclassification, Long Island investigators used a comprehensive questionnaire to obtain
detailed information on most study variables enhancing our ability to assess RPA and
control for confounding by important breast cancer risk factors.
Conclusion
In this large population-based study that included a life-course assessment of RPA and body
size, we found that frequent episodes of RPA (10 to 19 hrs/wk) at any intensity level during
the reproductive and postmenopausal years may have the greatest benefit for reducing the
risk of breast cancer. Our data indicate, however, that substantive postmenopausal weight
gain may eliminate the benefits of regular RPA. Collectively, these results suggest that
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women with can still reduce their breast cancer risk later in life by maintaining their weight
and engaging in moderate amounts of activity. Future investigations should include
populations with wide distributions of PA to confirm the non-linear dose-response found in
this study.
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